• 010-67890917
  • service@pioneerbio.com



LIA Products

Autoimmune diseases are characterized by autoantibody patterns found in patient sera. Our autoimmune line immune assays (LIAs) are developed for rapid autoantibody profiling.

LIAs are simple to use screening assays. By employing disease-specific antigens, up to 17 different autoantibodies can be differentiated with a single-shot assay. This state-of-theart autoimmune diagnostic tool is produced by spotting antigens in lines on a simple nitrocellulose membrane utilizing the newest technologies available in the market, including HUMAN’s patented epitope-preserving technology. Bound autoantibodies are visualized by using specific HRP-conjugated secondary antibodies that specifically target human autoantibodies and a LIA specific substrate. Samples positive for autoantibodies can be easily detected by comparing the pattern of brown lines to the standardized line (cut-off) that is also spotted on the LIAs. LIAs are ideal autoimmune diagnostic tools for screening and differential diagnosis as well as monitoring autoimmune patients by identifying specific autoantibodies in one shot.

We have strips of ANA, ENA, Myositis, Liver, Vasulitis.

Product features:

  • German original import
  • Up to 17 different autoantibodies can be differentiated with a single-shot assay
  • Quick and easy
  • Solutions for matching automation


Product Name:

HumaScan Software

Product use:

supporting the use of automated LIA processor, read the film results.


· Sensitive analysis system to ensure the objectivity and accuracy of results.
· Low-throughput and high-throughput at the same time.
· All strips images and patient result information can be stored.



Currently, Biopioneer has built a high efficiency distribution and service network all over the China, covers more than 20 provinces and autonomous regions. We’re pleased to have more partners whom willing to extend the business in China, though our sales channel, technical and training support at Great China Region. As well as more opportunities for academic exchanges and research.